Xintian Pharmaceuticals: Subsidiary obtains two invention patents.

Xintian Pharmaceutical announced that its wholly-owned subsidiary, Shanghai Suofang Pharmaceutical Technology Co., Ltd., recently received two invention patent certificates issued by the National Intellectual Property Administration. The patents are for "A method for constructing a complete belt soup fingerprint map and its application" and "A combination for moistening the intestines and promoting bowel movements and its application," with the authorization announcement date set for March 27, 2026. These two patents will be used in the production of new products by the company to enhance product quality stability and controllability. Although they will not have a significant impact on the company's production and operation, they will help improve the intellectual property protection system and strengthen core competitiveness.